Showing results (261-270 of 353) with videos related to

Sort By:
Pageof 36
Cancer|August 8, 2013
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes projectAndrew M Evens, Ann Vanderplas, Ann S LaCasce, et al.
Blood|November 26, 2014
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphomaMuhammad A Mir, Matthew J Maurer, Steven C Ziesmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent studyJonathan W Friedberg, Philip Cohen, Ling Chen, et al.
Cancer|December 11, 2014
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes projectBouthaina S Dabaja, Ann M Vanderplas, Allison L Crosby-Thompson, et al.
Blood Cancer Journal|October 16, 2025
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trialsSimonetta Viviani, Chiara Pavoni, Sally F Barrington, et al.
Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.
Journal of the National Cancer Institute|January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial RecommendationsCatherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Cancer Medicine|February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysisPallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Leukemia & Lymphoma|May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Pageof 36